Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Martin Meglasson

Affiliations

  • Chief Scientific Officer at Bellerophon Therapeutics Inc. (BLPH), 2015-05-22
  • V-P, Discovery Research at Ligand Pharmaceuticals Inc (LGND), 2010-05-11
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BLPH $8.40 712 Officer 19,098 2015-05-20 Filing
BLPH $12.00 12,000 Officer 18,386 2015-02-19 Filing
LGND $1.63 6,250 Officer 102,250 2010-05-11 Filing